Trade Ideas

Actionable trade ideas with entry/stop/target and risk framing.

Search Articles
Krystal Biotech, Inc. Common Stock
Jan 16, 2026

Krystal Biotech: Commercial Engine Is Running — Is the Stock Pricing Growth or Hype?

VYJUVEK is producing revenue and operating profit; the trade is a conditional long that bets commercialization momentum and pipeline optionality keep upward pressure.

Krystal Biotech (KRYS) has moved from development-mode to a commercial company with VYJUVEK producing consistent quarterly revenue and positive operat...

Trade Idea Long
Jan 16, 2026

Trip.com: Antitrust Overhang Is a Short-Term Headwind — Controlled Long Trade Looks Attractive

Large OTA with durable demand and margin upside; regulatory fear has pulled price below recent support — a tactical long for disciplined traders.

Trip.com (TCOM) is the largest online travel agent in China and benefits from a multi-year rebound in outbound travel and higher-margin international ...

Trade Idea Long
Spire Global, Inc.
Jan 16, 2026

Buy Spire Global Into a 2026 Growth Re-rate - Tactical Long with Defined Stops

Small satellites, recurring data revenue and an intact asset base make SPIR a recovered-but-undervalued way to play the space-data cycle into 2026

Spire Global looks cheap today relative to an asset-rich balance sheet and an annualized revenue run-rate north of $70M. The company is still loss-mak...

Trade Idea Long
Oklo Inc.
Jan 16, 2026

Turn Oklo Hype Into Income: A Covered-Call Play With Defined Risk

How to harvest premium from a high-volatility, pre-revenue nuclear story while keeping a clear stop and upside targets

Oklo (OKLO) is a high-volatility, pre-revenue advanced reactor developer riding fresh headlines and institutional interest. The company has a strong c...

Trade Idea Long
Larimar Therapeutics, Inc. Common Stock
Jan 16, 2026

Larimar (LRMR): Buy the Safety-Scare Dip — Market Is Underpricing a Potential Standard of Care

Clinical readouts and a strong cash runway make LRMR a high-risk, high-reward position after recent safety headlines.

Larimar Therapeutics saw its stock derate on safety noise and lawsuits in October 2025, but the company still controls a lead asset — CTI-1601 — w...

Trade Idea Long
Oneok, Inc.
Jan 16, 2026

Oneok (OKE): Buy the Growth + Yield Dip — A High-Conviction Long vs. Kinder Morgan's Comfort

Higher yield, heavier growth capex and improving free cash flow make Oneok an asymmetric trade for income-oriented growth investors

Oneok has pulled back from 12-month highs near $110 to the low $70s, creating an entry for investors who want a >5% yield plus organic cash-flow growt...

Trade Idea Long
Lockheed Martin Corp.
Jan 16, 2026

Why Lockheed's 'Golden Dome' Bet Is Make-or-Break — and How to Trade It

A conditional long: the program's approval and early wins could re-rate LMT; delays would keep the stock rangebound.

Lockheed Martin (LMT) is a cash-generative defense juggernaut, but it remains heavily exposed to the F-35 in Aeronautics. Management's next major stra...

Trade Idea Long
Nurix Therapeutics, Inc. Common stock
Jan 16, 2026

Nurix (NRIX): A Binary Clinical Re-rate With Cash to Burn and Data to Drive a Double

Take a position around $17–$20 ahead of pivotal and late-stage readouts — high risk, asymmetric upside if clinical data and regulatory pathlines hold.

Nurix is a small-molecule protein degradation and immunotherapy biotech sitting on meaningful cash, accelerating R&D spend and multiple clinical catal...

Trade Idea Long
Advanced Micro Devices
Jan 16, 2026

Buy AMD on the OpenAI Signal: AI Demand Is Real, So Is the Upside

CES/OpenAI momentum plus improving quarter-to-quarter data center sales create a tactical long with defined risk controls.

AMD's recent operational data and market chatter around an OpenAI signal mark a clear demand catalyst for its AI accelerators. Quarterly results show ...

Trade Idea Long
Advanced Micro Devices
Jan 16, 2026

AMD Conviction Report: Buy the AI-Driven Reopening, With Strict Stops

Data-center momentum + stronger cash flow justify a tactical long; keep risk tight around execution and competition

AMD is an actionable long on AI/data-center momentum and healthy underlying cash generation. Recent Q3 2025 results show improving margins and robust ...

Trade Idea Long
PepsiCo, Inc.
Jan 16, 2026

PepsiCo vs. Coca-Cola: Why I’m Long PepsiCo (PEP) for a Defensive Swing — Entry, Stops, Targets

Snack diversification and steady cash flow make PEP the lower-volatility play if the cola duel heats up under new Coke leadership.

PepsiCo’s mix (≈58% convenience foods, rest beverages), reliable free cash generation and growing quarterly operating income make it a pragmatic l...

Trade Idea Long
Kinder Morgan, Inc.
Jan 16, 2026

Kinder Morgan (KMI) — An AI-Driven Income & Value Trade

Buy a high-yield, cash-generative pipeline with optional upside from AI data-center demand; entry, stops and targets included.

Kinder Morgan is a classic midstream cash machine trading at a double-digit yield relative to its operating cash flow. Strong operating cash flow, a m...

Trade Idea Long